GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma
Currently, hormonal therapy for endometriosis faces challenges in achieving a balance between treatment and preserving the chance of pregnancy. Therefore, the development of non-hormonal therapy holds significant clinical importance. Angiogenesis …
Endometriosis is a widely spread disease that affects about 8% of the world's female population. This condition may be described as a spread of endometrial tissue apart from the uterine …
Authorities warn of increased brain tumour risk with specific contraceptive use CapeTown ETC
Study reveals endometriosis as a major cause of hospitalization in Australia MSN
This study aimed to assess the causal relationship between lipidome and female reproductive diseases (FRDs) using an advanced series of Mendelian randomization (MR) methods. This study utilized genome-wide association study …
SAHPRA warns of increased brain tumour risk with specific contraceptive use Swisher Post
SAHPRA Issues Warning on Meningioma Risk with Medroxyprogesterone Acetate Use, Updates Product Information Devdiscourse
Background Over the past decade, transvaginal ultrasound (TVUS) has revolutionized the diagnosis of deep endometriosis. We can now accurately describe and evaluate lesions in multiple compartments of the pelvis, increasing …